Joining FORCES is the FORCE newsletter with news, views and supportive information for individuals concerned about hereditary breast and ovarian cancer.
By Sue Friedman and Drea Thew
Presented at the 2006 Joining FORCEs Conference by Noah Kauff, MD, Clinical Genetics and Gynecology Services, Memorial Sloan-Kettering Cancer Center
Dr. Kauff discussed findings from the much publicized Women’s Health Initiative (WHI) study on hormone replacement therapy (HRT) in post-menopausal women:
Conclusions drawn from the study included:
The WHI study focused on women of average breast cancer risk who went through natural menopause. Dr. Kauff emphasized that it is unclear whether the results apply to high-risk women in their 30s and 40s who experienced surgical menopause.
Dr. Kauff explained data from other studies regarding HRT including:
Dr. Kauff introduced some non-hormonal options for managing menopausal symptoms: